Immunotherapy drug may help 'cure' advanced colorectal cancer without surgery

A new clinical trial has found that giving the immunotherapy drug pembrolizumab before surgery instead of chemotherapy can help improve outcomes for people with stage two or three MMR deficient/MSI-High colorectal cancer.